NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 35 filers reported holding NOVELION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $14,000 | -51.7% | 19,814 | -47.5% | 0.00% | – |
Q2 2019 | $29,000 | -69.1% | 37,717 | -50.4% | 0.00% | – |
Q1 2019 | $94,000 | -3.1% | 76,104 | -32.8% | 0.00% | – |
Q4 2018 | $97,000 | -85.8% | 113,217 | -51.1% | 0.00% | -100.0% |
Q3 2018 | $685,000 | -43.7% | 231,555 | -30.0% | 0.00% | -50.0% |
Q2 2018 | $1,217,000 | +889.4% | 330,677 | +838.0% | 0.00% | – |
Q1 2018 | $123,000 | -33.9% | 35,254 | -40.8% | 0.00% | – |
Q4 2017 | $186,000 | -42.9% | 59,582 | +28.7% | 0.00% | – |
Q3 2017 | $326,000 | -82.1% | 46,307 | -76.6% | 0.00% | -100.0% |
Q2 2017 | $1,823,000 | -48.2% | 197,519 | -39.7% | 0.00% | -50.0% |
Q1 2017 | $3,518,000 | – | 327,550 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|